Literature DB >> 15133686

Primary angiosarcoma of the non-irradiated parotid gland: a most uncommon, highly malignant tumor.

Glen E J Forton1, Geert Van Parys, Koen Hertveldt.   

Abstract

This case report discusses the clinical presentation, imaging, surgery and further treatment and course of a primary angiosarcoma of a non-irradiated parotid gland.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133686     DOI: 10.1007/s00405-004-0781-5

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  5 in total

1.  Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases.

Authors:  Julie C Fanburg-Smith; Mary A Furlong; Esther L B Childers
Journal:  Mod Pathol       Date:  2003-03       Impact factor: 7.842

2.  Radiation-associated angiosarcoma involving the parotid gland.

Authors:  M J Pérez del Río; J García-García; J M Díaz-Iglesias; M F Fresno
Journal:  Histopathology       Date:  1998-12       Impact factor: 5.087

3.  Facial nerve grading system.

Authors:  J W House; D E Brackmann
Journal:  Otolaryngol Head Neck Surg       Date:  1985-04       Impact factor: 3.497

4.  Angiosarcoma at unusual sites. A report of two cases with aspiration cytology and diagnostic pitfalls.

Authors:  S S Mullick; D R Mody; M R Schwartz
Journal:  Acta Cytol       Date:  1997 May-Jun       Impact factor: 2.319

Review 5.  Head and neck sarcoma: report of the Head and Neck Sarcoma Registry. Society of Head and Neck Surgeons Committee on Research.

Authors:  H J Wanebo; R J Koness; J K MacFarlane; F R Eilber; R M Byers; E G Elias; R H Spiro
Journal:  Head Neck       Date:  1992 Jan-Feb       Impact factor: 3.147

  5 in total
  1 in total

Review 1.  Ruptured angiosarcoma of the liver treated by emergency catheter-directed embolization.

Authors:  Christine Leowardi; Yura Hormann; Ulf Hinz; Moritz N Wente; Peter Hallscheidt; Christa Flechtenmacher; Markus W Buchler; Helmut Friess; Matthias H M Schwarzbach
Journal:  World J Gastroenterol       Date:  2006-02-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.